Moody's Investors Service Inc upgrade rating Upjohn Co's 400 mln dlrs debt. The agency study effect product Upjohn's earnings potential. Moody's ass effect growth broader diversification pharmaceutical cash flow operating performance. Moody's note pharmaceutical health-care market characterize great stability cash flow. Upjohn currently carry Aa-3 senior unsecured long-term debt industrial revenue bonds. The company's Prime-1 commercial paper review. Reuter 